Surgery Does Not Result in Better Outcomes for Pituitary Apoplexy
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 12, 2023 -- Three-month outcomes are similar with medical and surgical management of pituitary apoplexy (PA), according to a study recently published in the Journal of Clinical Endocrinology & Metabolism.
Adam N. Mamelak, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues established a multicenter, international prospective registry to compare presentation and outcomes in PA patients treated with surgery or medical management alone. A total of 100 PA patients were enrolled from 12 hospitals; the evaluation included 97 patients (67 surgical and 30 medical).
The researchers found that the groups had similar demographics, clinical features, presenting features, hormonal deficits, and imaging findings. In surgical patients, severe temporal visual field deficit was more common. Hormonal, visual, and oculomotor outcomes were similar at three and six months. No difference was seen in any outcome at three months on stratifying based on severity of visual fields. Outcomes were not affected by timing of surgery.
"These findings take some of the urgency out of managing these cases," Mamelak said in a statement. "Clinicians at these centers now know that they can safely manage these patients medically and transfer them when it's reasonable and available, or allow patients to forgo surgery entirely if they are comfortable with that."
Several authors disclosed ties to the medical device industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...
Few Patients With Positive Margins After Basal Cell Excision Have Recurrence
MONDAY, July 1, 2024 -- Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence...
Pediatric Surgical Opioid Prescribing Concentrated Among a Few Procedures
WEDNESDAY, June 26, 2024 -- Pediatric surgical opioid prescribing is concentrated among a small number of procedures, especially tonsillectomy and/or adenectomy, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.